News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1โ€“36
Matches
59
Sources here
17
Companies here
1
Search results Stored financial headlines

Active search

59 matching headlines

Ticker or company: XRNMain companies and provider mentions
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Global Medical REIT Inc. (NYSE:XRN) Given Consensus Rating of "Hold" by Analysts

Global Medical REIT Inc. (NYSE:XRN) has received a consensus "Hold" rating from nine research firms, with an average 12-month price target of $39.60 against its recent share price of $36.08. The company reported strong quarterly EPS of $4.78, significantly exceeding analyst expectations, and declared โ€ฆ

XRN main company
Sharemaestro market context Price below Trend Line 52 weeks +10.3% XRN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Chiron Real Estate (XRN) Turns Second Quarter Into A Pivot Point

On August 5, Chiron Real Estate Inc. (NYSE:XRN) posted second quarter 2026 results that read like two different companies stitched together. Net income attributable to common stockholders jumped to $63.3 million, or $4.78 per diluted share, a sharp reversal from a $0.8 million loss โ€ฆ

XRN main company
Sharemaestro market context Price below Trend Line 52 weeks +10.3% XRN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Global Medical REIT (NYSE:XRN) Earns Market Perform Rating from Analysts at Huntington

Huntington initiated coverage on Global Medical REIT (NYSE:XRN) with a "market perform" rating and a $37 price target. This rating contributes to an overall "Hold" consensus among analysts, with an average price target of $39.60. The company recently reported strong quarterly EPS of $4.78, โ€ฆ

XRN main company
Sharemaestro market context Price below Trend Line 52 weeks +10.3% XRN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Global Medical REIT Inc. (NYSE:XRN) Receives Consensus Recommendation of "Hold" from Analysts

Global Medical REIT Inc. (NYSE:XRN) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $40.25 against its current price of $37.11. The company significantly beat its last quarterly EPS estimates, reporting $4.78 versus an expected $0.83, and analysts โ€ฆ

XRN main company
Sharemaestro market context Price below Trend Line 52 weeks +10.3% XRN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Global Medical REIT Inc. (NYSE:XRN) Plans Monthly Dividend of $0.16

Global Medical REIT Inc. (NYSE:XRN) has declared a monthly dividend of $0.16 per share, payable on October 16th to shareholders of record on September 21st. While the current payout ratio is high at 3,840%, analysts anticipate future earnings will support a more sustainable 87.3%. โ€ฆ

XRN main company
Sharemaestro market context Price below Trend Line 52 weeks +10.3% XRN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Matthew Fitzsimmons Whitlock Buys 500 Shares of Global Medical REIT (NYSE:XRN) Stock

Matthew Fitzsimmons Whitlock, CIO of Global Medical REIT (NYSE:XRN), recently purchased 500 shares of the company's stock for $18,605, increasing his position by 50% to 1,500 shares. He also bought another 500 shares on August 17th. The company reported strong quarterly EPS of $4.78, โ€ฆ

XRN mentioned
Sharemaestro market context Price below Trend Line 52 weeks +10.3% XRN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Matthew Fitzsimmons Whitlock Acquires 500 Shares of Global Medical REIT (NYSE:XRN) Stock

Matthew Fitzsimmons Whitlock, CIO of Global Medical REIT (NYSE:XRN), recently purchased 500 shares of the company's stock for $18,605, increasing his position by 50% to 1,500 shares. He also bought another 500 shares on August 17th. The company reported strong quarterly EPS of $4.78, โ€ฆ

XRN mentioned
Sharemaestro market context Price below Trend Line 52 weeks +10.3% XRN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Global Medical REIT (NYSE:XRN) CEO Mark Okey Decker Jr Acquires 6,875 Shares of Stock

Global Medical REIT CEO Mark Okey Decker Jr. recently purchased 6,875 shares of the company's stock at an average price of $35.92, totaling approximately $246,950 and increasing his ownership to 75,199 shares. This acquisition signals management confidence, especially following a strong earnings report where โ€ฆ

XRN main company
Sharemaestro market context Price below Trend Line 52 weeks +10.3% XRN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Global Medical REIT (NYSE:XRN) COO Purchases $495,855.00 in Stock

Global Medical REIT's (NYSE:XRN) COO, Aaron Robert Roseth, recently purchased 13,500 shares of the company's stock for $495,855.00, increasing his direct ownership. The company reported strong quarterly earnings, significantly exceeding analyst estimates with an EPS of $4.78. Despite mixed analyst ratings, the company has โ€ฆ

XRN main company
Sharemaestro market context Price below Trend Line 52 weeks +10.3% XRN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Global Medical REIT (NYSE:XRN) CEO Mark Okey Decker Jr Buys 550 Shares

Global Medical REIT CEO Mark Okey Decker Jr. recently purchased 6,875 shares of the company's stock at an average price of $35.92, totaling approximately $246,950 and increasing his ownership to 75,199 shares. This acquisition signals management confidence, especially following a strong earnings report where โ€ฆ

XRN main company
Sharemaestro market context Price below Trend Line 52 weeks +10.3% XRN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Charles Fitzgerald Acquires 27,600 Shares of Global Medical REIT (NYSE:XRN) Stock

Global Medical REIT Director Charles Fitzgerald recently purchased 27,600 shares of the company's stock for approximately $991,944, increasing his direct ownership to 124,893 shares. The company reported strong quarterly earnings, surpassing analyst estimates, and currently holds a consensus "Hold" rating from analysts with an โ€ฆ

XRN mentioned
Sharemaestro market context Price below Trend Line 52 weeks +10.3% XRN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Global Medical REIT (NYSE:XRN) CEO Buys $287,040.00 in Stock

Global Medical REIT (NYSE:XRN) CEO Mark Okey Decker Jr. recently purchased 8,000 shares of the company's stock for $287,040, increasing his total ownership to 67,774 shares. This acquisition follows a strong earnings report where the company surpassed analyst expectations with an EPS of $4.78. โ€ฆ

XRN main company
Sharemaestro market context Price below Trend Line 52 weeks +10.3% XRN stored weekly price path from 17 Oct 2025 to 9 Oct 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context